Benzydamine Hydrochloride
This medicine should always be used exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.
Tantum Verde Lemon Flavor contains the active substance benzydamine, which belongs to the group of indole non-steroidal anti-inflammatory drugs (NSAIDs) for topical and systemic use. Benzydamine has anti-inflammatory, analgesic, and local anesthetic and antiseptic effects. The medicine is well absorbed locally, reaching high concentrations in inflamed tissues. The medicine is generally well tolerated and suitable for local treatment of inflammation symptoms. Suck the medicine. The medicine is used to treat discomfort and symptoms (pain, redness, swelling) associated with inflammatory conditions of the mouth and throat. If there is no improvement after 3 days or the patient feels worse, they should consult their doctor.
Before starting to use Tantum Verde Lemon Flavor, the patient should discuss it with their doctor or pharmacist.
The patient should inform their doctor or pharmacist about all medicines they are currently using or have recently used, as well as any medicines they plan to use. The interaction of Tantum Verde Lemon Flavor with other medicines has not been studied.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine. Tantum Verde Lemon Flavor should not be used during pregnancy or breastfeeding.
Local use of benzydamine in recommended doses does not affect the ability to drive or use machines. Tantum Verde Lemon Flavor containsaspartame (E 951), isomalt (E 953), butylhydroxyanisole (E 320), and fragrances that may cause allergic reactions, such as benzyl alcohol, citral, citronellol, d-limonene, eugenol, geraniol, and linalol (contained in the lemon and mint flavor composition).
The medicine contains 3.26 mg of aspartame in each hard lozenge. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria, a rare genetic disorder in which phenylalanine accumulates in the body due to its impaired excretion.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains flavor compositions with benzyl alcohol, citral, citronellol, d-limonene, eugenol, geraniol, and linalol, which may cause allergic reactions. The medicine contains 0.00052 mg of benzyl alcohol in each hard lozenge. Benzyl alcohol may cause allergic reactions and mild local irritation. Patients with liver or kidney diseases should consult their doctor before using the medicine, as a large amount of benzyl alcohol may accumulate in their body and cause side effects (metabolic acidosis).
The medicine may cause local skin reactions (such as contact dermatitis) or eye and mucous membrane irritation.
This medicine should always be used exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist. The recommended dosage is 1 lozenge 3 times a day. The lozenge should be sucked slowly. Do not swallow or chew. Do not use a higher dose than recommended. Continuous treatment should not exceed 7 days.
Due to the pharmaceutical form, the medicine should not be used in children under 6 years of age. In children between 6 and 11 years of age, the medicine should be used under adult supervision. If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
In case of accidental ingestion of too many lozenges, the patient should immediately consult their doctor, taking the package of the medicine with them. The doctor will take appropriate action. Very rarely, symptoms of overdose (excitement, convulsions, sweating, incoordination, tremors, vomiting) have been reported in children after ingestion of benzydamine-containing medicines in doses about 100 times higher than the dose contained in a single lozenge.
The patient should not use a double dose to make up for a missed dose. In case of any further doubts about using this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Uncommonside effects (occurring in less than 1 in 100 people): skin reactions due to hypersensitivity to light. Rareside effects (occurring in less than 1 in 1,000 people): burning or dryness in the mouth. If these symptoms occur, they can be reduced by slowly drinking a glass of water in small sips. Very rareside effects (occurring in less than 1 in 10,000 people): laryngospasm, angioedema. Side effects of unknown frequency(frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any possible side effects not listed in this leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children. Store in a temperature below 25°C, in the original packaging. Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Biconvex hard lozenges, yellow in color, with a lemon flavor. Lozenges in a blister pack of PVC/PE/PVdC/Aluminum or packaged individually in paraffin-coated paper, and then in bags of PE/paper/Aluminum, all in a cardboard box. Each package contains 20 or 30 hard lozenges.
Angelini Pharma S.p.A.
Viale Amelia 70, 00181 Rome, Italy
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
Via Vecchia del Pinocchio 22
60131 Ancona, Italy
PIERRE FABRE MEDICAMENT PRODUCTION
Site Diététique et Pharmacie
Zone Industrielle de la Coudette
32290 Aignan, France
Angelini Pharma Polska Sp. z o.o.
Aleje Jerozolimskie 181B
02-222 Warsaw
tel.: (22) 70 28 200
e-mail: angelini@angelini.pl
The patient leaflet in a format suitable for the blind and visually impaired is available at the representative of the marketing authorization holder's office.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.